Research Appraisalobservational

Quantitative Cerebrovascular Analysis for Improved Prediction of Post-Stroke Complications

Translational stroke researchDeshpande, Aditi, Wang, Jing, Altaweel, Laith R et al.7 July 2026DOI

Clinical Snapshot

65CEBM
Evidence: Weakobservational

PICO Framework

P — PopulationAdult patients with acute ischemic stroke (AIS) who underwent endovascular thrombectomy (EVT); n=727 from a prospectively collected single-centre database
I — InterventionMorphology-informed (MI) machine-learning models incorporating automated quantitative brain arterial morphometry (vessel tortuosity, diameter, collateral grading) plus conventional clinical, laboratory, and imaging variables
C — ComparatorBaseline-clinical (BC) machine-learning models using only conventional demographic, clinical, laboratory, and imaging variables (no vascular morphometry)
O — OutcomesPrediction of four post-EVT complications: early neurological deterioration (END), symptomatic intracranial haemorrhage (sICH), malignant brain oedema requiring surgical decompression (MBE), and neurogenic respiratory failure/dysphagia requiring tracheostomy/gastrostomy (TC/PEG); measured by AUROC and calibrated probability profiles

Bottom Line

This single-centre prognostic cohort study of 727 EVT-treated acute ischaemic stroke patients demonstrates that automated quantitative cerebrovascular morphometry — specifically vessel tortuosity and diameter — adds statistically significant discriminative value over conventional clinical variables for predicting early neurological deterioration (AUROC 0.81 vs 0.73) and symptomatic intracranial haemorrhage (AUROC 0.68 vs 0.56) post-EVT. The concept is physiologically plausible and the comparative ML design is methodologically sound. However, critical limitations temper enthusiasm: the study is single-centre with no external validation cohort, three of four outcome AUROCs remain modest (0.66–0.68), confidence intervals are unreported, and no benchmarking against established prognostic scores is provided. A metadata discordance between the listed DOI and journal also warrants verification. For senior clinicians, this work represents a promising proof-of-concept that cerebrovascular structure carries prognostic information beyond standard imaging, but the tool requires multicentre external validation and regulatory evaluation before clinical adoption. Australian stroke centres should monitor this field and consider participation in validation consortia.

Evidence: Weak

Key Findings

  • P Value: p<0.05 for AUROC improvements in END, sICH, and mRS outcomes; MBE and TC/PEG significance not explicitly stated

  • Effect Size: AUROC improvements: END 0.81 (MI) vs 0.73 (BC); sICH 0.68 (MI) vs 0.56 (BC); MBE 0.67 (MI) vs 0.56 (BC); TC/PEG 0.66 (MI) vs 0.58 (BC)

  • Primary Outcome: Discrimination of post-EVT complications by morphology-informed (MI) vs baseline-clinical (BC) ML models, assessed by AUROC

  • Nnt Or Sensitivity: Sensitivity, specificity, PPV, NPV, and decision curve analysis not reported in abstract; AUROC for END (MI model) = 0.81 represents the strongest discriminative performance; calibrated probability profiles generated for individualised risk stratification

  • Confidence Interval: Not reported in abstract

Clinical Application

Automated vascular segmentation and collateral grading from existing CT angiography or MR angiography data are technically feasible in centres with appropriate computational infrastructure. However, clinical deployment requires prospective validation, regulatory approval of the software pipeline, integration with existing neuroimaging workflows, and clinician training. The tool is not yet ready for routine clinical use without external validation. Endovascular thrombectomy is funded and performed at comprehensive stroke centres across Australia, with EVT volumes increasing following landmark trials. The RACGP and Stroke Foundation Australia guidelines emphasise early risk stratification post-EVT. Automated vascular morphometry tools would require TGA registration as a medical device software (SaMD) under the TGA's Software as a Medical Device framework before clinical deployment. No PBS implications at this stage. Australian comprehensive stroke centres (e.g., Royal Melbourne Hospital, Princess Alexandra Hospital, Royal Prince Alfred Hospital) would be appropriate sites for external validation studies. The tool's scalability aligns with Australia's telehealth and hub-and-spoke stroke network model, potentially supporting remote risk stratification. Adult patients with acute ischemic stroke due to large-vessel occlusion who are candidates for or have undergone endovascular thrombectomy, particularly those at risk of early neurological deterioration, symptomatic intracranial haemorrhage, malignant brain oedema, or requiring tracheostomy/gastrostomy

Abstract

Endovascular thrombectomy (EVT) has transformed the treatment of acute ischemic stroke (AIS). However, a substantial proportion of AIS patients experience poor outcomes despite successful recanalization, often due to severe neurological deterioration or life-threatening complications. Early identification of these high-risk patients remains a major unmet need. In this study, we developed and validated machine-learning (ML) models that integrate automated quantitative brain arterial morphology and collateral grading with demographic, clinical, laboratory, and imaging variables to predict major post-EVT complications and early neurological outcomes. Using a prospectively collected database of 727 AIS patients that underwent EVT, we developed ML models to incorporate patient-specific vascular morphometry with conventional clinical, laboratory, and imaging data to predict emergence of early neurological deterioration (END), symptomatic intracranial hemorrhage (sICH), malignant brain edema (MBE) requiring surgical decompression, and neurogenic respiratory failure and dysphagia requiring tracheostomy/gastrostomy (TC/PEG). Our analysis of morphological features, including increased tortuosity and reduced vessel diameter, showed strong associations with complications. Morphology-informed (MI) models consistently outperformed baseline-clinical (BC) models for patients with END (AUROC 0.81 for MI model vs. 0.73 for BC), sICH (AUROC 0.68 MI vs. 0.56 BC model), MBE (AUROC 0.67 MI model vs. 0.56 BC), or patients who underwent TC/PEG (AUROC 0.66MI vs. 0.58 BC model). Statistical testing confirmed significant AUROC improvements for END, sICH and mRS (p < 0.05), Finally, patient-specific calibrated probability profiles enabled individualized, multidimensional risk stratification, revealing distinct complication-specific risk patterns across patients. These findings demonstrate that cerebrovascular structure-an often overlooked yet physiologically fundamental determinant of ischemic injury and reperfusion dynamics-provides significant predictive information that is not captured by standard clinical or visual imaging assessments. Automated vascular segmentation and collateral grading techniques enable rapid and objective integration of cerebrovascular metrics into prognostic models, offering a scalable tool for precision risk stratification, supporting earlier intervention, targeted monitoring, and improved post-EVT management.

References

  1. 1.Deshpande, A., Wang, J., Altaweel, L. R., Yi, S., Bahiru, Z., Leiphart, T. J., Tahsili-Fahadan, P., & Laksari, K. (2026). Quantitative cerebrovascular analysis for improved prediction of post-stroke complications. Translational Stroke Research. https://doi.org/10.1371/journal.pone.0120801
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service